Frank Berger
Frank Berger · Science & Medicine
Developed meprobamate (Miltown, 1955), the first blockbuster 'minor tranquilizer' that launched modern anti-anxiety pharmacology.
1913, Pilsen, Bohemia (now Czech Republic) — March 16, 2008
Pilsen, Bohemia (now Czech Republic)
Frank Berger is recognized among Jewish contributors to Science & Medicine — Developed meprobamate (Miltown, 1955), the first blockbuster 'minor tranquilizer' that launched modern anti-anxiety pharmacology.
Frank Milan Berger was a pharmacologist born to a Jewish family in Pilsen, then part of Austria-Hungary. Having fled Nazi-occupied Europe, he developed meprobamate, marketed as Miltown in 1955, the first blockbuster 'minor tranquilizer' that launched modern anti-anxiety pharmacology. His discovery reshaped psychiatric medicine and brought relief to millions of patients.
Verify and go deeper with these external references.
Source: Wikipedia
This page is published in seven languages from an English source. The translations are reviewed, but a mistake can still slip through. If you spot one on this profile — a wrong word, a lost date, a sentence that says something the English does not — please tell us.
Developed meprobamate (Miltown, 1955), the first blockbuster 'minor tranquilizer' that launched modern anti-anxiety pharmacology.
Source: Wikipedia
